Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 12/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | GALR3 | O60755 | 1/20 | 0.50 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.50 |
| ▸ | DOT1L | Q8TEK3 | 3/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.45 |
| ▸ | CDK1 | P06493 | 2/20 | 0.42 |
| ▸ | CDK2 | P24941 | 2/20 | 0.42 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.42 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.42 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HSPA8 | P11142 | 1/20 | 0.40 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3234421 | 1.00 | ADK (0.50) | ADKNPC1GALR3S1PR4ALDH1A1 | |
| SCHEMBL13495010 | 1.00 | ADK (0.50) | ADKNPC1GALR3S1PR4ALDH1A1 | |
| SCHEMBL3226243 | 0.93 | ADK (0.47) | ADKNPC1GALR3S1PR4ALDH1A1 | |
| SCHEMBL3226222 | 0.93 | ADK (0.47) | ADKNPC1GALR3S1PR4ALDH1A1 | |
| SCHEMBL3229936 | 0.90 | ADK (0.44) | ADKNPC1GALR3S1PR4ALDH1A1 | |
| SCHEMBL3234007 | 0.90 | ADK (0.44) | ADKNPC1GALR3S1PR4ALDH1A1 | |
| SCHEMBL3229959 | 0.90 | ADK (0.44) | ADKNPC1GALR3S1PR4ALDH1A1 | |
| SCHEMBL3233982 | 0.90 | ADK (0.44) | ADKNPC1GALR3S1PR4ALDH1A1 | |
| SCHEMBL3224465 | 0.88 | ADK (0.43) | ADKNPC1GALR3S1PR4ALDH1A1 | |
| SCHEMBL13494168 | 0.88 | ADK (0.43) | ADKNPC1GALR3S1PR4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12083185-B2 | Small polymeric carriers for delivery of agents | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2024-09-10 | — | — | US | claimed |
| US-12466849-B2 | Anti-viral and anti-tumoral compounds | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2025-11-11 | — | — | US | disclosed |
| US-20250281574-A1 | COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL INFECTIONS AND OTHER RESPIRATORY DISORDERS | XEQUEL BIO INC (US) | 2025-09-11 | — | — | US | disclosed |
| US-20250161334-A1 | Method Of Treating, Reducing, Or Alleviating A Medical Condition In A Patient | PEYMAN GHOLAM A (US) | 2025-05-22 | — | — | US | disclosed |
| US-20250057975-A1 | SMALL POLYMERIC CARRIERS FOR DELIVERY OF AGENTS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2025-02-20 | — | — | US | disclosed |
| US-12226478-B2 | Method of treating, reducing, or alleviating a medical condition in a patient | PEYMAN GHOLAM A (US) | 2025-02-18 | — | — | US | disclosed |
| US-12083185-B2 | Small polymeric carriers for delivery of agents | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2024-09-10 | — | — | US | disclosed |
| WO-2023212446-A1 | COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL INFECTIONS AND OTHER RESPIRATORY DISORDERS | XEQUEL BIO, INC. (US) | 2023-11-02 | — | — | WO | disclosed |
| US-20230338520-A1 | Method Of Treating, Reducing, Or Alleviating A Medical Condition In A Patient | PEYMAN GHOLAM A (US) | 2023-10-26 | — | — | US | disclosed |
| EP-4228656-A2 | ANTI-VIRAL AND ANTI-TUMORAL COMPOUNDS | Yeda Research and Development Co. Ltd (IL) | 2023-08-23 | — | — | EP | disclosed |
| WO-2021209425-A9 | ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E | Janssen Pharmaceuticals, Inc. (US) | 2022-12-22 | — | — | WO | disclosed |
| US-20220202933-A1 | Method Of Treating, Reducing, Or Alleviating A Medical Condition In A Patient | PEYMAN GHOLAM A (US) | 2022-06-30 | — | — | US | disclosed |
| WO-2021209425-A1 | ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E | Janssen Sciences Ireland Unlimited Company (IE) | 2021-10-21 | — | — | WO | disclosed |
| US-20100144655-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-06-10 | — | — | US | disclosed |
| US-20100144655-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-06-10 | — | — | US | disclosed |
| US-20100144655-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-06-10 | — | — | US | disclosed |
| WO-2010015637-A1 | NEW ANTIVIRAL MODIFIED NUCLEOSIDES | NOVARTIS AG (CH) | 2010-02-11 | — | — | WO | disclosed |
| WO-2010015643-A1 | NEW ANTIVIRAL MODIFIED NUCLEOSIDES | NOVARTIS AG (CH) | 2010-02-11 | — | — | WO | disclosed |
| WO-2010015637-A1 | NEW ANTIVIRAL MODIFIED NUCLEOSIDES | NOVARTIS AG (CH) | 2010-02-11 | — | — | WO | disclosed |
| WO-2010015643-A1 | NEW ANTIVIRAL MODIFIED NUCLEOSIDES | NOVARTIS AG (CH) | 2010-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12466849-B2 | Anti-viral and anti-tumoral compounds | EIF2AK2, NSUN2, SARS1 | ADK 1513/4885NPC1 1602/4885GALR3 2657/4885 |
| US-20250057975-A1 | SMALL POLYMERIC CARRIERS FOR DELIVERY OF AGENTS | CD44, PGF, SLC46A1 | ADK 4798/4885NPC1 781/4885GALR3 1331/4885 |
| US-12083185-B2 | Small polymeric carriers for delivery of agents | CD44, PGF, SLC46A1 | ADK 4798/4885NPC1 781/4885GALR3 1331/4885 |
| US-20100144655-A1 | ORGANIC COMPOUNDS | OAT, MAVS, HAVCR2 | ADK 3634/4885NPC1 88/4885GALR3 3128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.